3C3 Stock Chart & Stats
€19.90
€0.60(2.86%)
At close: 4:00 PM EDT
€19.90
€0.60(2.86%)
Day’s Range― - ―
52-Week Range€19.00 - €26.80
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€515.35M
Enterprise Value€670.73
Total Cash (Recent Filing)€90.74M
Total Debt (Recent Filing)€133.07M
Price to Earnings (P/E)22.5
Beta0.75
Next Earnings
Nov 09, 2026EPS Estimate
0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.14
Shares Outstanding23,966,995
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.34
Price to Book (P/B)1.08
Price to Sales (P/S)0.44
P/FCF Ratio30.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€28.18Price Target Upside41.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.35
Revenue Forecast (FY)€1.33B
Bulls Say, Bears Say
Bulls Say
Deleveraging And LiquidityLower leverage and stable-to-rising equity strengthen Kimball’s financial resilience and reduce interest burden. This gives the company greater flexibility to fund capital spending, integrate acquisitions, and withstand cyclical demand without relying as heavily on external financing.
Medical Segment MomentumMedical is becoming a larger and faster-growing part of the business, improving Kimball’s exposure to regulated healthcare applications. Continued organic growth and rising mix could support steadier revenue, better program visibility, and stronger long-term operating leverage.
Helvoet Expands Medical CapabilitiesHelvoet broadens Kimball’s medical manufacturing capabilities, geographic footprint, and customer reach across Europe and India. The combination supports a more integrated healthcare platform and provides a structural avenue for scale, cross-selling, and future medical program growth.
Bears Say
Multi-year Revenue ContractionSeveral consecutive years of declining revenue indicate that Kimball has not yet restored broad-based demand after its strong 2023 performance. Persistent contraction can weaken operating leverage, limit reinvestment capacity, and make future growth more dependent on acquisitions or a few expanding programs.
Automotive And Industrial WeaknessWeakness in two important end markets creates a durable offset to Medical growth, particularly while automotive demand and North American HVAC activity remain pressured. Continued declines could reduce factory utilization, constrain revenue diversification, and delay a broader recovery in the base business.
Thin Margins And Ramp PressureThin profitability leaves limited room for execution setbacks, and Indianapolis ramp costs are expected to weigh on earnings before the facility reaches scale. Higher SG&A and launch spending may suppress near-term cash conversion and delay the margin benefits of future growth.
3C3 FAQ
What was Kimball Electronics’s price range in the past 12 months?
Kimball Electronics lowest stock price was €19.00 and its highest was €26.80 in the past 12 months.
What is Kimball Electronics’s market cap?
Kimball Electronics’s market cap is €515.35M.
When is Kimball Electronics’s upcoming earnings report date?
Kimball Electronics’s upcoming earnings report date is Nov 09, 2026 which is in 48 days.
How were Kimball Electronics’s earnings last quarter?
Kimball Electronics released its earnings results on Aug 12, 2026. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of €0.336 by -€0.344.
Is Kimball Electronics overvalued?
According to Wall Street analysts Kimball Electronics’s price is currently Undervalued.
Does Kimball Electronics pay dividends?
Kimball Electronics does not currently pay dividends.
What is Kimball Electronics’s EPS estimate?
Kimball Electronics’s EPS estimate is 0.33.
How many shares outstanding does Kimball Electronics have?
Kimball Electronics has 23,966,995 shares outstanding.
What happened to Kimball Electronics’s price movement after its last earnings report?
Kimball Electronics reported an EPS of -€0.009 in its last earnings report, missing expectations of €0.336. Following the earnings report the stock price went down -2.778%.
Which hedge fund is a major shareholder of Kimball Electronics?
Currently, no hedge funds are holding shares in DE:3C3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kimball Electronics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€28.18 (41.62% Upside)
€28.18 (41.62% Upside)
Blogger Sentiment
Bullish
DE:3C3 Sentiment 100%
Sector Average 61%
Sector Average 61%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.83%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Kimball Electronics
Kimball Electronics, Inc. specializes in providing comprehensive contract electronics manufacturing (CEM) and an array of diversified production solutions, catering to clients across the automotive, medical, industrial, and public safety sectors. Their extensive service portfolio encompasses initial design and development support, robust supply chain management, and agile rapid prototyping alongside streamlined product introduction capabilities. Key competencies also include comprehensive product design, rigorous process validation and qualification, and the industrialization and automation of complex manufacturing workflows. The company excels in reliability testing, subjecting products to a range of environmental conditions, and is proficient in the production and testing of printed circuit board assemblies. They also handle the assembly, production, and packaging of medical devices, including disposables and other non-electronic items, as well as electronic and non-electronic drug delivery systems. Additionally, their expertise extends to the design engineering and manufacturing of automation equipment, test and inspection equipment, and precision molded plastics, complemented by software design services and holistic product life cycle management. With a significant global operational presence, Kimball Electronics conducts business in the United States, China, Mexico, Poland, Romania, Thailand, and Vietnam. Founded in 1961, the company maintains its headquarters in Jasper, Indiana.
3C3 Company Deck
3C3 Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was largely constructive: management highlighted stabilization of the base business, strong cash generation, meaningful balance sheet improvement, gross margin expansion, and an accretive acquisition (Helvoet) that supports FY2027 growth guidance of 7%–9%. Medical continues to be the primary growth engine. Offsetting these positives are persistent weakness in Automotive and Industrial segments, near-term margin pressure from ramping the Indianapolis CDMO facility (an estimated ~$6.5M–$7M drag), a very high Q4 effective tax rate that distorted adjusted results, and expected working capital headwinds and FX translation risk associated with Helvoet. Overall, the positives (cash, guidance, Medical momentum, acquisition synergies, and improved margins/interest costs) outweigh the negatives, though several risks remain in the near term.View all DE:3C3 earnings summaries3C3 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€28.18
▲(41.62% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Espey Mfg & Electronics
―
Preformed Line Products Company
―
Ultralife
―
SKYX Platforms
―
AirJoule Technologies
―






